Page 2 - Van Spall News Today

Systematic risk assessment of patients with acute heart failure in the ED significantly cut their 30-day and 20-month cardiovascular hospitalizations.

An intensive treatment strategy of rapid up-titration of guideline-directed medication and close follow-up after an acute heart failure admission was readily accepted by patients because it reduced symptoms, improved quality of life, and reduced the risk of 180-day all-cause death or heart failure readmission compared with usual care.

CHICAGO — Use of a point-of-care tool to support clinical decision-making in addition to rapid outpatient follow-up reduced the risk for death or CV hospitalizations for patients with acute HF presenting to the ED. “Implementation of this approach may lead to a pathway for early discharge from the hospital or emergency department and improved patient outcomes,” Douglas S. Lee,

Pathways for HF patients picked for early discharge versus admission

This article explores the misconceptions of science that were adopted during Covid, nudged along by buzzwords like “Trust the science”.

The FDA has set standards for patient-reported outcomes in research and care. In CVD, very few tools available meet the bar.

Many young doctors and doctors in training experience bullying from colleagues but often dont report it, fearing retribution.

The study has multiple limitations, including the exclusion of women, but mortality and stroke benefits were evident.

Comprehensive cardiovascular screening fell short of significantly reducing all-cause mortality in men aged 65-74, but some benefits were seen in the whole group and for mortality in those younger than 70.

Contracting COVID-19 radically changed Tracey Thompsons life. The Toronto woman says the enduring illness and lack of substantive financial support has led her to begin the process of ending her life.